Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

NCT04743544 · clinicaltrials.gov ↗

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Adverse Drug Reactions

Interventions

DRUG: Voriconazole

Sponsor

Dokuz Eylul University

Collaborators

[object Object]